Rapid assessment of in vitro expanded human regulatory T cell function

Journal of Immunological Methods

Volumn 372, Issue 1-2, 2011, Pages 95-106

  Ruitenberg, Joyce J ^a   Boyce, Christopher ^a   Hingorani, Ravi ^a   Putnam, Amy ^b   A Ghanekar, Smita ^a  

^a BD BIOSCIENCES   (United States)

^b UCSF Diabetes Center   (United States)

Author keywords

Activation; Flow cytometry; Potency; Regulatory T cells; Suppression

Indexed keywords

BIOLOGICAL MARKER; CD40 LIGAND; CD45RA ANTIGEN; CD69 ANTIGEN; INTERLEUKIN 7 RECEPTOR; SUPPRESSOR FACTOR;

ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; CD4+ CD25+ T LYMPHOCYTE; CELL EXPANSION; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CD40 LIGAND; CELL PROLIFERATION; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; LECTINS, C-TYPE; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES, REGULATORY;

EID: 80052500407     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2011.07.001     Document Type: Article

References (34)

1. Ashokkumar C., Gupta A., Sun Q., Ningappa M.B., Higgs B.W., Mazariegos G., Fazzolare T., Remaley L., Soltys K., Bond G., Abu-Elmagd K., Sindhi R. Allospecific CD154+ T cells identify rejection-prone recipients after pediatric small-bowel transplantation. Surgery 2009, 146:166-173.
2. Ashokkumar C., Talukdar A., Sun Q., Higgs B.W., Janosky J., Wilson P., Mazariegos G., Jaffe R., Demetris A., Dobberstein J., Soltys K., Bond G., Thomson A.W., Zeevi A., Sindhi R. Allospecific CD154+ T cells associate with rejection risk after pediatric liver transplantation. Am. J. Transplant. 2009, 9:179-191.
3. Bacchetta R., Passerini L., Gambineri E., Dai M., Allan S.E., Perroni L., Dagna-Bricarelli F., Sartirana C., Matthes-Martin S., Lawitschka A., Azzari C., Ziegler S.F., Levings M.K., Roncarolo M.G. Defective regulatory and effector T cell functions in patients with FOXP3 mutations. J. Clin. Invest. 2006, 116:1713-1722.
4. Baecher-Allan C., Brown J.A., Freeman G.J., Hafler D.A. CD4+CD25 high regulatory cells in human peripheral blood. J. Immunol. 2001, 167:1245-1253.
5. Baecher-Allan C., Viglietta V., Hafler D.A. Inhibition of human CD4(+)CD25(+high) regulatory T cell function. J. Immunol. 2002, 169:6210-6217.
6. Bluestone J.A., Abbas A.K. Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 2003, 3:253-257.
7. Bluestone J.A., Tang Q. Therapeutic vaccination using CD4+CD25+ antigen-specific regulatory T cells. Proc. Natl. Acad. Sci. U.S.A. 2004, 101(Suppl 2):14622-14626.
8. Brusko T.M., Hulme M.A., Myhr C.B., Haller M.J., Atkinson M.A. Assessing the in vitro suppressive capacity of regulatory T cells. Immunol. Invest. 2007, 36:607-628.
9. Dieckmann D., Plottner H., Berchtold S., Berger T., Schuler G. Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J. Exp. Med. 2001, 193:1303-1310.
10. Fehervari Z., Sakaguchi S. CD4+ Tregs and immune control. J. Clin. Invest. 2004, 114:1209-1217.
11. Fontenot J.D., Gavin M.A., Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 2003, 4:330-336.
12. Hoffmann P., Eder R., Boeld T.J., Doser K., Piseshka B., Andreesen R., Edinger M. Only the CD45RA+ subpopulation of CD4+CD25 high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion. Blood 2006, 108:4260-4267.
13. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061.
14. Jonuleit H., Schmitt E., Stassen M., Tuettenberg A., Knop J., Enk A.H. Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 2001, 193:1285-1294.
15. Levings M.K., Sangregorio R., Roncarolo M.G. Human CD25(+)CD4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 2001, 193:1295-1302.
16. Liu W., Putnam A.L., Xu-Yu Z., Szot G.L., Lee M.R., Zhu S., Gottlieb P.A., Kapranov P., Gingeras T.R., de St Fazekas, Groth B., Clayberger C., Soper D.M., Ziegler S.F., Bluestone J.A. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J. Exp. Med. 2006, 203:1701-1711.
17. Maecker H.T., Picker L.J., Maino V.C. Flow cytometric analysis of cytokines. Manual of Clinical Laboratory Immunology, Vol. 6th ed 2002, 338-346. ASM Press, Washington, D.C.
18. Maecker H.T., Moon J., Bhatia S., Ghanekar S.A., Maino V.C., Payne J.K., Kuus-Reichel K., Chang J.C., Summers A., Clay T.M., Morse M.A., Lyerly H.K., DeLaRosa C., Ankerst D.P., Disis M.L. Impact of cryopreservation on tetramer, cytokine flow cytometry, and ELISPOT. BMC Immunol. 2005, 6:17.
19. Mahic M., Yaqub S., Bryn T., Henjum K., Eide D.M., Torgersen K.M., Aandahl E.M., Tasken K. Differentiation of naive CD4+ T cells into CD4+CD25+FOXP3+ regulatory T cells by continuous antigen stimulation. J. Leukoc. Biol. 2008, 83:1111-1117.
20. Miyara M., Sakaguchi S. Natural regulatory T cells: mechanisms of suppression. Trends Mol. Med. 2007, 13:108-116.
21. Miyara M., Yoshioka Y., Kitoh A., Shima T., Wing K., Niwa A., Parizot C., Taflin C., Heike T., Valeyre D., Mathian A., Nakahata T., Yamaguchi T., Nomura T., Ono M., Amoura Z., Gorochov G., Sakaguchi S. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 2009, 30:899-911.
22. Oberg H.H., Wesch D., Lenke J., Kabelitz D. An optimized method for the functional analysis of human regulatory T cells. Scand. J. Immunol. 2006, 64:353-360.
23. Oberle N., Eberhardt N., Falk C.S., Krammer P.H., Suri-Payer E. Rapid suppression of cytokine transcription in human CD4+CD25 T cells by CD4+Foxp3+ regulatory T cells: independence of IL-2 consumption, TGF-beta, and various inhibitors of TCR signaling. J. Immunol. 2007, 179:3578-3587.
24. Peng G., Guo Z., Kiniwa Y., Voo K.S., Peng W., Fu T., Wang D.Y., Li Y., Wang H.Y., Wang R.F. Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function. Science 2005, 309:1380-1384.
25. Powrie F., Maloy K.J. Immunology. Regulating the regulators. Science 2003, 299:1030-1031.
26. Sakaguchi S. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 2000, 101:455-458.
27. Sakaguchi S., Powrie F. Emerging challenges in regulatory T cell function and biology. Science 2007, 317:627-629.
28. Seddiki N., Santner-Nanan B., Martinson J., Zaunders J., Sasson S., Landay A., Solomon M., Selby W., Alexander S.I., Nanan R., Kelleher A., de St Fazekas, Groth B. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J. Exp. Med. 2006, 203:1693-1700.
29. Seddiki N., Santner-Nanan B., Tangye S.G., Alexander S.I., Solomon M., Lee S., Nanan R., de Saint Fazekas, Groth B. Persistence of naive CD45RA+ regulatory T cells in adult life. Blood 2006, 107:2830-2838.
30. Tran D.Q., Ramsey H., Shevach E.M. Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. Blood 2007, 110:2983-2990.
31. Valmori D., Merlo A., Souleimanian N.E., Hesdorffer C.S., Ayyoub M. A peripheral circulating compartment of natural naive CD4 Tregs. J. Clin. Invest. 2005, 115:1953-1962.
32. Venken K., Thewissen M., Hellings N., Somers V., Hensen K., Rummens J.L., Stinissen P. A CFSE based assay for measuring CD4+CD25+ regulatory T cell mediated suppression of auto-antigen specific and polyclonal T cell responses. J. Immunol. Methods 2007, 322:1-11.
33. Walker M.R., Kasprowicz D.J., Gersuk V.H., Benard A., Van Landeghen M., Buckner J.H., Ziegler S.F. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. J. Clin. Invest. 2003, 112:1437-1443.
34. Zheng Y., Manzotti C.N., Liu M., Burke F., Mead K.I., Sansom D.M. CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells. J. Immunol. 2004, 172:2778-2784.